tirzepatide use What Is Used for? Approved and Potential Uses Tirzepatide Dual Agonist (GLP-1/GIP) |

The pharmacokinetics of LY3437943 (retatrutide) support once-weekly administration due to an elimination half-life of approximately 6 days. Jastreboff AM et al., Nature Medicine, 2023 This extended half-life is made possible by attaching a fatty acid chain to the peptide, allowing it to bind to albumin a common protein in your blood that acts like a slow-release carrier

It's suitable for patients who have struggled with traditional weight loss methods

Tuy nhin, bn nn nhn thc r ri ro ny, c bit nu c tin s ri lon tm thn nh trm cm

The broader anti-inflammatory effects of GLP-1 receptor agonists observed in cardiovascular and metabolic research have generated interest in potential applications beyond diabetes and obesity

New findings may emerge which may contradict or confirm the information provided in this article